BSE - Delayed Quote INR

Gujarat Themis Biosyn Limited (GUJTHEM.BO)

312.05
-13.85
(-4.25%)
At close: 3:44:59 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Tapas Bhudebendranath Guhathakurata Chief Executive Officer -- -- --
Mr. Bhavik Shah Chief Financial Officer -- -- --
Mr. Do-Seon Kim Chief Technical Officer -- -- --
Mr. Vineet G. Gawankar Company Secretary & Compliance Officer -- -- --
Mr. Rajneesh Kedarnath Anand Senior Executive -- -- 1954

Gujarat Themis Biosyn Limited

Themis House
11/12 Udyog Nagar S.V Road Goregaon (West)
Mumbai, 400104
India
91 22 6760 7080 https://www.gtbl.in
Sector: 
Healthcare
Full Time Employees: 
159

Description

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

Corporate Governance

Gujarat Themis Biosyn Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 24, 2025 at 10:59 AM UTC - July 28, 2025 at 12:00 PM UTC

Gujarat Themis Biosyn Limited Earnings Date

Recent Events

July 15, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.